KRISPY KREME INC (DNUT) Stock Fundamental Analysis

NASDAQ:DNUT • US50101L1061

3.615 USD
-0.13 (-3.6%)
Last: Mar 2, 2026, 12:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, DNUT scores 1 out of 10 in our fundamental rating. DNUT was compared to 125 industry peers in the Hotels, Restaurants & Leisure industry. DNUT may be in some trouble as it scores bad on both profitability and health. DNUT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • DNUT had negative earnings in the past year.
  • In the past year DNUT had a positive cash flow from operations.
  • In the past 5 years DNUT reported 4 times negative net income.
  • Of the past 5 years DNUT 4 years had a positive operating cash flow.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

  • DNUT has a Return On Assets of -19.63%. This is amonst the worse of the industry: DNUT underperforms 92.80% of its industry peers.
  • DNUT's Return On Equity of -76.15% is on the low side compared to the rest of the industry. DNUT is outperformed by 70.40% of its industry peers.
Industry RankSector Rank
ROA -19.63%
ROE -76.15%
ROIC N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

  • Looking at the Gross Margin, with a value of 28.67%, DNUT is doing worse than 79.20% of the companies in the same industry.
  • DNUT's Gross Margin has been stable in the last couple of years.
  • DNUT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for DNUT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.15, we must say that DNUT is in the distress zone and has some risk of bankruptcy.
  • DNUT has a Altman-Z score of 0.15. This is amonst the worse of the industry: DNUT underperforms 84.00% of its industry peers.
  • A Debt/Equity ratio of 1.35 is on the high side and indicates that DNUT has dependencies on debt financing.
  • DNUT's Debt to Equity ratio of 1.35 is in line compared to the rest of the industry. DNUT outperforms 51.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 0.15
ROIC/WACCN/A
WACC7.02%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • DNUT has a Current Ratio of 0.36. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DNUT's Current ratio of 0.36 is on the low side compared to the rest of the industry. DNUT is outperformed by 86.40% of its industry peers.
  • A Quick Ratio of 0.30 indicates that DNUT may have some problems paying its short term obligations.
  • DNUT has a worse Quick ratio (0.30) than 86.40% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.3
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • DNUT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -183.33%.
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.88%

3.2 Future

  • DNUT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.42% yearly.
  • The Revenue is expected to grow by 7.09% on average over the next years.
EPS Next Y5.34%
EPS Next 2Y33.06%
EPS Next 3Y8.75%
EPS Next 5Y12.42%
Revenue Next Year-2.32%
Revenue Next 2Y2.01%
Revenue Next 3Y7.09%
Revenue Next 5Y7.09%

3.3 Evolution

DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2030 0 0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • DNUT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DNUT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • DNUT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DNUT is more expensive than 68.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.51
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.06%
EPS Next 3Y8.75%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.73%, DNUT has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.10, DNUT pays a better dividend. On top of this DNUT pays more dividend than 92.80% of the companies listed in the same industry.
  • DNUT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.73%

5.2 History

  • DNUT has been paying a dividend for over 5 years, so it has already some track record.
  • DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • The earnings of DNUT are negative and hence is the payout ratio. DNUT will probably not be able to sustain this dividend level.
DP-3.5%
EPS Next 2Y33.06%
EPS Next 3Y8.75%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

More info and screens

Find the best dividend stocksShow peers with best dividend

KRISPY KREME INC

NASDAQ:DNUT (3/2/2026, 12:02:04 PM)

3.615

-0.13 (-3.6%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners43.74%
Inst Owner Change1.24%
Ins Owners3.64%
Ins Owner Change0.06%
Market Cap619.25M
Revenue(TTM)N/A
Net Income(TTM)-510.43M
Analysts52.31
Price Target4.43 (22.54%)
Short Float %28.53%
Short Ratio9.17
Dividend
Industry RankSector Rank
Dividend Yield 3.73%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP-3.5%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-117.45%
Min EPS beat(2)-353.46%
Max EPS beat(2)118.57%
EPS beat(4)1
Avg EPS beat(4)-81.52%
Min EPS beat(4)-353.46%
Max EPS beat(4)118.57%
EPS beat(8)2
Avg EPS beat(8)-67.78%
EPS beat(12)5
Avg EPS beat(12)-46.53%
EPS beat(16)6
Avg EPS beat(16)-38.2%
Revenue beat(2)0
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-4.66%
Max Revenue beat(4)-1.53%
Revenue beat(8)1
Avg Revenue beat(8)-1.98%
Revenue beat(12)3
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.39%
PT rev (1m)-1.42%
PT rev (3m)1.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.6%
EPS NY rev (1m)8.3%
EPS NY rev (3m)18.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF 38.82
P/B 0.92
P/tB N/A
EV/EBITDA 21.51
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)0.09
OCFY2.58%
SpS8.96
BVpS3.91
TBVpS-4.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.63%
ROE -76.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.67%
FCFM N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 12.25
Cap/Depr 83.67%
Cap/Sales 7.48%
Interest Coverage N/A
Cash Conversion 21.56%
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.3
Altman-Z 0.15
F-Score5
WACC7.02%
ROIC/WACCN/A
Cap/Depr(3y)96.05%
Cap/Depr(5y)105.48%
Cap/Sales(3y)7.25%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y5.34%
EPS Next 2Y33.06%
EPS Next 3Y8.75%
EPS Next 5Y12.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.88%
Revenue Next Year-2.32%
Revenue Next 2Y2.01%
Revenue Next 3Y7.09%
Revenue Next 5Y7.09%
EBIT growth 1Y-1143.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year501.71%
EBIT Next 3Y85.12%
EBIT Next 5Y57.43%
FCF growth 1Y-709.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.9%
OCF growth 3Y-31.28%
OCF growth 5Y-10.72%

KRISPY KREME INC / DNUT FAQ

What is the ChartMill fundamental rating of KRISPY KREME INC (DNUT) stock?

ChartMill assigns a fundamental rating of 1 / 10 to DNUT.


Can you provide the valuation status for KRISPY KREME INC?

ChartMill assigns a valuation rating of 0 / 10 to KRISPY KREME INC (DNUT). This can be considered as Overvalued.


Can you provide the profitability details for KRISPY KREME INC?

KRISPY KREME INC (DNUT) has a profitability rating of 1 / 10.


What is the earnings growth outlook for KRISPY KREME INC?

The Earnings per Share (EPS) of KRISPY KREME INC (DNUT) is expected to grow by 5.34% in the next year.